Metraipolis › archive › dc_7478a5b0a4e2

Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks — Europe PMC PMID:40788464

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40788464
DOI
10.1007/s13659-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-10T18:02:14.833Z
SHA-256 of the archived text
03d45213a337ff3d77ac2b418298f227cdeb66d1418f596f65022b28ca0c2747
Stable URL of this page
https://metraipolis.com/documento/dc_7478a5b0a4e2

How to cite

Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks — Europe PMC PMID:40788464 — Europe PMC (en), https://europepmc.org/article/MED/40788464 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7478a5b0a4e2 (Metraipolis archive dc_7478a5b0a4e2, sha256 03d45213a337ff3d77ac2b418298f227cdeb66d1418f596f65022b28ca0c2747)
BibTeX
@misc{dc7478a5b0a4e2,
  title = {Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks — Europe PMC PMID:40788464},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40788464},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7478a5b0a4e2; sha256 03d45213a337ff3d77ac2b418298f227cdeb66d1418f596f65022b28ca0c2747},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40788464. Agents can read the archived copy with the MCP tool read_document.